| 000 | 01301 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516185033.0 | ||
| 264 | 0 | _c20141009 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1534-6277 | ||
| 024 | 7 |
_a10.1007/s11864-013-0263-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMehta, Amitkumar | |
| 245 | 0 | 0 |
_aHow do I recommend extended adjuvant hormonal therapy? _h[electronic resource] |
| 260 |
_bCurrent treatment options in oncology _cMar 2014 |
||
| 300 |
_a55-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aDrug Substitution |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTamoxifen _xadministration & dosage |
| 700 | 1 | _aCarpenter, John T | |
| 773 | 0 |
_tCurrent treatment options in oncology _gvol. 15 _gno. 1 _gp. 55-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11864-013-0263-3 _zAvailable from publisher's website |
| 999 |
_c23367379 _d23367379 |
||